Free Trial

Equities Analysts Issue Forecasts for Exponent Q3 Earnings

Exponent logo with Business Services background

Key Points

  • William Blair has lowered its Q3 2025 earnings estimate for Exponent to $0.50 per share, down from $0.51, while the full-year earnings consensus is $1.98 per share.
  • Exponent recently reported Q2 earnings of $0.52 per share, exceeding estimates, with a revenue of $132.87 million, a 7.3% increase year-over-year.
  • The company announced a quarterly dividend of $0.30 per share, with a dividend yield of 1.8%, set to be paid on September 19th.
  • MarketBeat previews the top five stocks to own by September 1st.

Exponent, Inc. (NASDAQ:EXPO - Free Report) - William Blair reduced their Q3 2025 earnings estimates for shares of Exponent in a note issued to investors on Friday, August 1st. William Blair analyst A. Nicholas now forecasts that the business services provider will earn $0.50 per share for the quarter, down from their prior forecast of $0.51. The consensus estimate for Exponent's current full-year earnings is $1.98 per share. William Blair also issued estimates for Exponent's Q4 2025 earnings at $0.42 EPS.

Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The company had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.57 EPS.

Exponent Price Performance

EXPO stock opened at $68.33 on Monday. The stock has a market capitalization of $3.47 billion, a PE ratio of 34.17 and a beta of 0.89. The company's 50-day moving average is $74.71 and its 200-day moving average is $80.15. Exponent has a 1 year low of $63.81 and a 1 year high of $115.75.

Hedge Funds Weigh In On Exponent

Several large investors have recently added to or reduced their stakes in EXPO. LPL Financial LLC lifted its position in Exponent by 16.0% in the 4th quarter. LPL Financial LLC now owns 69,873 shares of the business services provider's stock valued at $6,226,000 after acquiring an additional 9,658 shares in the last quarter. Pictet Asset Management Holding SA lifted its position in Exponent by 8.7% in the 4th quarter. Pictet Asset Management Holding SA now owns 6,822 shares of the business services provider's stock valued at $608,000 after acquiring an additional 547 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Exponent by 1,061.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 85,790 shares of the business services provider's stock valued at $7,644,000 after acquiring an additional 78,401 shares in the last quarter. CIBC Private Wealth Group LLC lifted its position in Exponent by 3.8% in the 4th quarter. CIBC Private Wealth Group LLC now owns 4,418 shares of the business services provider's stock valued at $394,000 after acquiring an additional 161 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in Exponent by 5.4% in the 4th quarter. Franklin Resources Inc. now owns 3,710 shares of the business services provider's stock valued at $331,000 after acquiring an additional 189 shares in the last quarter. Institutional investors own 92.37% of the company's stock.

Insider Transactions at Exponent

In related news, VP John Pye sold 2,000 shares of the firm's stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Joseph Rakow sold 1,573 shares of the firm's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock valued at $489,120 in the last 90 days. 1.60% of the stock is currently owned by corporate insiders.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, September 5th. Exponent's dividend payout ratio is 60.00%.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines